• Log In
  • Sign Up
    • I post my Forever Labs related thoughts on the Forever Labs blog.

      I’m also just getting active on Twitter ( It’s a personal account, so I am not always speaking in my capacity at Forever Labs on it. Such is the nature of communication these days. I do share my paintings there. You don’t need art school to paint!

    • Thanks, MountainMom! It’s difficult to predict the progress of therapeutics, especially for a treatment like heterochronic transplantation, which is currently in the animal-based research phase. The rate of MSC therapeutic development makes me quite optimistic, but I am hesitant to make predictions. The administration is likely to be intravenous, as many of the MSCs introduced by i.v. return to where they originate, and many MSC therapies in development for age-related diseases are administered this way. I will say that I am keen on using my own cells for heterochronic transplantation, and I do predict that I will be able to do so in a safe and efficacious manner. In fact, we hope to facilitate it by partnering in a clinical trial. I’d love to be able to say “In 10 years we will be doing this...”, but that wouldn’t be an honest answer. I do believe that having cells that are 10 years younger will be an asset however, whether for heterochronic transplantation, or treatment for injury or disease.